FR3081709B1 - Composition topique sterile pour utilisation chez les nouveau-nes pour maintenir, reguler et normaliser le microbiote cutane - Google Patents

Composition topique sterile pour utilisation chez les nouveau-nes pour maintenir, reguler et normaliser le microbiote cutane Download PDF

Info

Publication number
FR3081709B1
FR3081709B1 FR1854600A FR1854600A FR3081709B1 FR 3081709 B1 FR3081709 B1 FR 3081709B1 FR 1854600 A FR1854600 A FR 1854600A FR 1854600 A FR1854600 A FR 1854600A FR 3081709 B1 FR3081709 B1 FR 3081709B1
Authority
FR
France
Prior art keywords
newborns
regulate
maintain
skin
normalize
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1854600A
Other languages
English (en)
Other versions
FR3081709A1 (fr
Inventor
Audrey Mercier
Julie Pinson
Veronique Guibert-Barrois
Joanna Bellicard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilas 3
Original Assignee
Lilas 3
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilas 3 filed Critical Lilas 3
Priority to FR1854600A priority Critical patent/FR3081709B1/fr
Publication of FR3081709A1 publication Critical patent/FR3081709A1/fr
Application granted granted Critical
Publication of FR3081709B1 publication Critical patent/FR3081709B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une composition topique stérile pour utilisation chez les nouveau-nés pour maintenir, réguler et normaliser le microbiote cutané. Ladite composition comprend, dans un milieu physiologiquement acceptable, un agent prébiotique consistant en un mélange fructo-oligosaccharide et du fructose. Elle appartient au domaine des soins cutanés apportés aux nouveau-nés par le personnel médical et les parents.
FR1854600A 2018-05-29 2018-05-29 Composition topique sterile pour utilisation chez les nouveau-nes pour maintenir, reguler et normaliser le microbiote cutane Active FR3081709B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1854600A FR3081709B1 (fr) 2018-05-29 2018-05-29 Composition topique sterile pour utilisation chez les nouveau-nes pour maintenir, reguler et normaliser le microbiote cutane

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1854600A FR3081709B1 (fr) 2018-05-29 2018-05-29 Composition topique sterile pour utilisation chez les nouveau-nes pour maintenir, reguler et normaliser le microbiote cutane
FR1854600 2018-05-29

Publications (2)

Publication Number Publication Date
FR3081709A1 FR3081709A1 (fr) 2019-12-06
FR3081709B1 true FR3081709B1 (fr) 2020-10-09

Family

ID=63637981

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1854600A Active FR3081709B1 (fr) 2018-05-29 2018-05-29 Composition topique sterile pour utilisation chez les nouveau-nes pour maintenir, reguler et normaliser le microbiote cutane

Country Status (1)

Country Link
FR (1) FR3081709B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022184547A1 (fr) * 2021-03-04 2022-09-09 Unilever Ip Holdings B.V. Utilisation de fructanes pour fournir des bénéfices de soin cutané

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902660B1 (fr) * 2006-06-23 2010-09-24 Didier Lopez Sterilisation de produit cosmetique
GB2498543A (en) * 2012-01-19 2013-07-24 Gemma Clarke Topical prebiotic powder composition and uses thereof

Also Published As

Publication number Publication date
FR3081709A1 (fr) 2019-12-06

Similar Documents

Publication Publication Date Title
CO6311007A2 (es) Composicion farmaceutica que comprende un agente que activa las celulas t regulatorias cd4+cd25+, efectiva a dosis bajas
CO6311006A2 (es) Composicion farmaceutica que comprende un agente que activa las celulas t regulatorias cd4+cd25+ efectiva a dosis altas
EA201591403A1 (ru) Спиролактамные модуляторы рецептора nmda и их применение
CL2019000248A1 (es) Moduladores del receptor nmda espiro-lactam y uso de los mismos
EA201591405A1 (ru) Спиролактамные модуляторы nmda-рецептора и их применение
CY1125025T1 (el) 2-φορμυλ-3-υδροξυφαινυλοξυμεθυλ ενωσεις ικανες ρυθμισης αιμοσφαιρινης
CL2016001940A1 (es) Composición farmacéutica que contiene un compuesto derivado de imidazo[1,5-a]indol, [1,2,4]triazolo[3,4-a]isoindol, [1,2,3]triazolo[5,1-a]isoindol ó 1,4-dihidroindeno[1,2-c] sustituidos y un segundo agente terapéutico; y su uso tratar la inmunosupresión mediada por indoleamina 2,3-dioxigenasa (ido), estimular la proliferación de células t, inhibir la degradación de triptófano en células que expresa ido, para tratar una enfermedad asociada con ido como una infección o cáncer (divisional de solicitud n° 2649-2015).
CO2019000938A2 (es) Moduladores nmda espiro-lactam y métodos de uso de los mismos
CL2019000247A1 (es) Moduladores del receptor nmda espiro-lactam y uso de los mismos.
CL2019000249A1 (es) Moduladores del receptor nmda spiro-lactam y bis-spiro-lactam y uso de los mismos.
EA201690044A1 (ru) Модуляторы ядерного транспорта и их применение
EA201892657A1 (ru) Спиролактамовые модуляторы nmda-рецептора и их применение
PE20142314A1 (es) Composiciones intranasales de dexmedetomidina y metodos de uso de ellas
CO6382132A2 (es) Tratamiento de pirfenidona para pacientes con funcion hepatica atipica
EA201492050A1 (ru) Модуляторы ядерного транспорта и их применение
EA201591404A1 (ru) Спиролактамные модуляторы рецептора nmda и их применение
EA201591402A1 (ru) Спиролактамные модуляторы nmda-рецептора и их применение
CL2019000246A1 (es) Moduladores del receptor nmda espiro-lactam y uso de los mismos.
CO6220969A2 (es) Adminsitracion semanal de inhibidores de peptidasa de dipeptidilo
CO6771406A2 (es) Una composición combinada
ECSP14023048A (es) Agentes terapéuticos para administración subcutánea optimizados
PH12014502331A1 (en) Orally available pharmaceutical formulation suitable for improved management of movement disorders
CL2009000919A1 (es) Uso de dronedarona o una sal farmaceuticamente aceptable para preparar un medicamento util en la prevencion y/o tratamiento de la hipocalemia.
WO2015048503A3 (fr) Modulateurs négatifs n-arylméthyl sulfonamide de nr2a
CR20110226A (es) Composición para tratar enfermedad

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

EXTE Extension to a french territory

Extension state: PF

PLSC Publication of the preliminary search report

Effective date: 20191206

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6